Scarica l'app Stockscreener
117.67
5.41%
-6.73
Dopo l'orario di chiusura:
117.00
-0.67
-0.57%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ILMN Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$124.40
Aprire:
$123
Volume 24 ore:
1.22M
Relative Volume:
0.63
Capitalizzazione di mercato:
$17.99B
Reddito:
$4.34B
Utile/perdita netta:
$850.00M
Rapporto P/E:
21.54
EPS:
5.4635
Flusso di cassa netto:
$921.00M
1 W Prestazione:
-5.36%
1M Prestazione:
-12.49%
6M Prestazione:
+28.33%
1 anno Prestazione:
+43.01%
Intervallo 1D:
$116.73
$123.32
Intervallo di 1 settimana:
$116.73
$128.74
Portata 52W:
$68.70
$155.53
Illumina Inc Stock (ILMN) Company Profile
Nome
Illumina Inc
Settore
Industria
Telefono
(858) 202-4500
Indirizzo
5200 ILLUMINA WAY, SAN DIEGO, CA
Compare ILMN vs TMO, DHR, IDXX, A, WAT
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ILMN
Illumina Inc
|
117.67 | 19.02B | 4.34B | 850.00M | 921.00M | 5.4635 |
TMO
Thermo Fisher Scientific Inc
|
473.36 | 181.60B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
181.52 | 133.08B | 24.57B | 3.60B | 5.26B | 5.051 |
IDXX
Idexx Laboratories Inc
|
558.32 | 45.65B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
110.24 | 32.07B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
289.16 | 29.49B | 3.17B | 642.63M | 516.49M | 10.77 |
Illumina Inc Stock (ILMN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-12 | Downgrade | Daiwa Securities | Outperform → Neutral |
| 2025-07-11 | Downgrade | Scotiabank | Sector Outperform → Sector Perform |
| 2025-03-04 | Reiterato | Citigroup | Neutral |
| 2025-02-28 | Downgrade | HSBC Securities | Buy → Hold |
| 2025-02-10 | Downgrade | Barclays | Equal Weight → Underweight |
| 2025-02-07 | Downgrade | TD Cowen | Buy → Hold |
| 2024-12-11 | Downgrade | Citigroup | Buy → Neutral |
| 2024-11-12 | Ripresa | Morgan Stanley | Equal-Weight |
| 2024-10-17 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2024-08-28 | Aggiornamento | Argus | Hold → Buy |
| 2024-08-16 | Aggiornamento | Daiwa Securities | Neutral → Buy |
| 2024-08-14 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2024-08-14 | Aggiornamento | TD Cowen | Hold → Buy |
| 2024-07-10 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-06-03 | Ripresa | Jefferies | Hold |
| 2024-01-16 | Downgrade | HSBC Securities | Buy → Hold |
| 2024-01-04 | Downgrade | TD Cowen | Outperform → Market Perform |
| 2023-12-18 | Aggiornamento | Scotiabank | Sector Perform → Sector Outperform |
| 2023-12-15 | Aggiornamento | Bernstein | Underperform → Mkt Perform |
| 2023-12-14 | Iniziato | Guggenheim | Buy |
| 2023-12-14 | Iniziato | Stephens | Overweight |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2023-12-12 | Downgrade | BofA Securities | Neutral → Underperform |
| 2023-12-11 | Aggiornamento | Citigroup | Sell → Neutral |
| 2023-11-10 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2023-09-28 | Iniziato | Bernstein | Underperform |
| 2023-07-05 | Ripresa | JP Morgan | Neutral |
| 2023-01-25 | Downgrade | Argus | Buy → Hold |
| 2023-01-05 | Iniziato | Scotiabank | Sector Perform |
| 2022-12-12 | Downgrade | Citigroup | Neutral → Sell |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-10-04 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2022-09-28 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2022-08-25 | Iniziato | Credit Suisse | Neutral |
| 2022-07-13 | Downgrade | Barclays | Equal Weight → Underweight |
| 2022-01-18 | Aggiornamento | Stifel | Hold → Buy |
| 2022-01-11 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2022-01-07 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2022-01-06 | Ripresa | Morgan Stanley | Equal-Weight |
| 2022-01-06 | Ripresa | Piper Sandler | Overweight |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-08-19 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2021-06-01 | Aggiornamento | Evercore ISI | Underperform → In-line |
| 2021-03-31 | Downgrade | Atlantic Equities | Overweight → Neutral |
| 2021-03-31 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2021-03-03 | Iniziato | Barclays | Underweight |
| 2020-12-22 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2020-12-17 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2020-10-13 | Downgrade | Guggenheim | Buy → Neutral |
| 2020-09-30 | Iniziato | Atlantic Equities | Overweight |
| 2020-09-29 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2020-09-22 | Downgrade | Stifel | Buy → Hold |
| 2020-09-22 | Downgrade | UBS | Buy → Neutral |
| 2020-09-21 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2020-09-21 | Downgrade | JP Morgan | Overweight → Neutral |
| 2020-09-09 | Iniziato | Morgan Stanley | Equal-Weight |
| 2020-08-07 | Downgrade | Evercore ISI | In-line → Underperform |
| 2020-08-07 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2020-07-07 | Downgrade | Guggenheim | Buy → Neutral |
| 2020-04-24 | Downgrade | Citigroup | Buy → Neutral |
| 2020-04-21 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2020-01-08 | Iniziato | Wells Fargo | Underweight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2020-01-02 | Downgrade | Evercore ISI | Outperform → In-line |
| 2019-11-15 | Iniziato | Stifel | Buy |
| 2019-10-25 | Iniziato | Guggenheim | Buy |
Mostra tutto
Illumina Inc Borsa (ILMN) Ultime notizie
RadNet, Evolent Health, Illumina, Charles River Laboratories, and Repligen Stocks Trade Down, What You Need To Know - TradingView
Vanguard realigns reporting; subsidiaries to report separately (Illumina, ILMN) - Stock Titan
Wealth Enhancement Advisory Services LLC Grows Stock Position in Illumina, Inc. $ILMN - MarketBeat
Illumina Inc. Stock: Dominant Player in Genomic Sequencing Faces Competitive and Regulatory Challeng - AD HOC NEWS
Whole Genome Sequencing Market Key Aspects, Benefits, - openPR.com
DRAGEN v4.5: Expanding Accurate Variant Discovery Across the Entire Genome - Illumina
Illumina Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Argus raises Illumina stock price target to $145 on new products By Investing.com - Investing.com South Africa
Argus raises Illumina stock price target to $145 on new products - Investing.com
Block Trades: Will Illumina Inc benefit from seasonality2026 Macro Impact & Verified Short-Term Trading Plans - baoquankhu1.vn
Illumina Inc. stock navigates Grail divestiture challenges amid biotech sector pressures - AD HOC NEWS
Illumina Inc stock faces headwinds amid Grail divestiture and biotech sector pressures - AD HOC NEWS
Short Squeeze: Will Illumina Inc benefit from seasonality2026 Closing Moves & Weekly Top Gainers Trade List - baoquankhu1.vn
Illumina Inc. stock faces ongoing challenges from Grail divestiture and genomics market pressures - AD HOC NEWS
Illumina Inc. stock outperforms competitors on strong trading day - MarketWatch
Illumina Inc. stock faces headwinds amid Grail divestiture scrutiny and biotech sector slowdown - AD HOC NEWS
Here's why Illumina (ILMN) is a strong growth stock - msn.com
Illumina price gives in to negative pressureForecast today24-03-2026 - Economies.com
US Multiomic Market Set to Boom Rapidly, Witnessing Strong - openPR.com
ILMN Stock Price, Quote & Chart | ILLUMINA INC (NASDAQ:ILMN) - ChartMill
Illumina : CSR Report (2025 illumina france gender pay gap english) - marketscreener.com
Illumina : CSR Report (2025 illumina gender pay gap uk) - marketscreener.com
A $175 Million Move Into Sotera Health Signals Potential Opportunity Amid 21% Stock Drop - The Motley Fool
Prediction Tool Market Poised for Rapid Growth as AI and Genomics - openPR.com
Canaccord reiterates Hold on Illumina stock amid Roche competition - investing.com
Nordea Investment Management AB Boosts Stake in Illumina - National Today
Nordea Investment Management AB Has $124.15 Million Stake in Illumina, Inc. $ILMN - MarketBeat
Illumina TruPath™ Genome supports a more comprehensive genome analysis - Illumina
Illumina Inc. stock faces renewed scrutiny amid Grail divestiture delays and biotech sector headwind - AD HOC NEWS
Illumina Introduces a New AI algorithm PromoterAI: Stock to Gain? - MSN
Swiss Life Asset Management Ltd Purchases 67,772 Shares of Illumina, Inc. $ILMN - MarketBeat
Here’s Why Illumina Could Continue Its 47% Last Year Rally - TIKR.com
Illumina, Inc. (NASDAQ:ILMN) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Illumina Inc. stock underperforms Friday when compared to competitors - MarketWatch
Illumina and Labcorp Expand Precision Oncology Testing Partnership - Oncodaily
Illumina, Inc. $ILMN Shares Sold by CIBC Private Wealth Group LLC - MarketBeat
Illumina Says China Removed Ban on Importing DNA Sequencers - MSN
ILMN Stock Gains Following Expanded Collaboration With Labcorp - TradingView
In Canada, researching the use of AI to accelerate answers for rare disease - Illumina
DNA Sequencing Market size to hit $108.95 Billion by 2035 | Top - openPR.com
JPMorgan Chase Boosts Illumina Stake by 17.5% - National Today
JPMorgan Chase & Co. Acquires 124,246 Shares of Illumina, Inc. $ILMN - MarketBeat
Illumina and Labcorp expand cancer testing collaboration - Investing.com India
Illumina, Labcorp Expand Collaboration to Advance Precision Oncology Testing - marketscreener.com
Synthetic Biology Market to Reach US$ 67.47 Billion by 2033 | - openPR.com
Illumina and Labcorp expand cancer testing collaboration By Investing.com - Investing.com UK
Life Sciences Tools & Services Stocks Q4 Earnings: Illumina (NASDAQ:ILMN) Firing on All Cylinders - Yahoo Finance
Illumina and Labcorp expand collaboration to broaden access to precision oncology testing - PR Newswire
Investment Report: Is Illumina Inc stock a good dividend stockPortfolio Update Report & Weekly Breakout Watchlists - baoquankhu1.vn
U.S. Bioinformatics Market Is Booming Rapidly with Strong - openPR.com
How The Illumina (ILMN) Story Is Shifting With 2026 Expectations And Mixed Street Views - Yahoo Finance
Illumina Inc Azioni (ILMN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.33%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):